oral glutathione skin whitening trial for lightening Combination of topical and oral
Description
This is a less common but theoretically plausible area of research
For instance, the novel TAAR1 agonist compound 50B demonstrates favorable BBB permeability and does not induce EPS, suggesting that strategic drug design can enhance efficacy while minimizing adverse effects (181)
DS: Data curation, Conceptualization, Writing original draft, Software
Three More Real Patient Cases (Composite Profiles) Case 4, 38-year-old marketing director
